1-nitro-2-phenylethane has been researched along with monocrotaline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, RS; Caetano-Souza, MM; da Silva, JKR; Dos Santos, AA; Duarte, GP; Gonzaga-Costa, K; Lahlou, S; Magalhães, PJC; Martins, CS; Roque, CR; Sousa-Brito, HL; Vasconcelos-Silva, AA | 1 |
1 other study(ies) available for 1-nitro-2-phenylethane and monocrotaline
| Article | Year |
|---|---|
The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Benzene Derivatives; Echocardiography; Endothelium, Vascular; Hemodynamics; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Wistar; Soluble Guanylyl Cyclase; Vascular Remodeling | 2021 |